Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Pharmacy Compounding Accreditation Board (PCAB) is a specialized accreditation program that evaluates compounding pharmacies against rigorous national standards. Established in 2004 by eight leading pharmacy organizations, PCAB aims to provide a quality-assurance system for the compounding pharmacy profession. In 2014, the organization was integrated into the Accreditation Commission for Health Care (ACHC), where it continues to operate as a service. PCAB accreditation signifies that a pharmacy has met high-level standards for sterile and non-sterile compounding, including compliance with USP <795> and USP <797> guidelines. The accreditation process involves an extensive on-site evaluation and a review of the pharmacy's policies and procedures to ensure patient safety and high-quality compounded preparations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pharmacy Compounding Accreditation Board.